Status:
UNKNOWN
DAPSONE GEL7.5%Versus Trichloroacetic Acid 20% ON ACNE VULGARIS
Lead Sponsor:
Assiut University
Conditions:
Acne Vulgaris
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
Acne vulgaris, a chronic inflammatory skin disorder, is one of the most prevalent diseases that effects more than 80% of the population worldwide . A variety of factors such as genetics, hormones, infec...
Detailed Description
Chemical peeling can target the pathogenic factors recognized in acne and treat present primary and secondary lesions, it also improves the pigmentary changes seen with acne, and hastes the time taken...
Eligibility Criteria
Inclusion
- Both males and females will be included.
- Patients older than 12 years of age.
- Patients with mild and moderate AV.
- Patients had not received any topical or systemic treatment for AV during the previous 2 weeks
Exclusion
- Severe acne.
- Patients under treatment with contraceptive pills or any kind of systemic or topic acne medication (isotretinoin, antibiotics, topical products).
- History of hypertrophic/keloid scar formation.
- Pregnancy, breast feeding.
- Recurrent herpes infection.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05296460
Start Date
September 1 2022
End Date
October 1 2023
Last Update
April 1 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.